nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroxoline—METAP2—Diseases associated with visual transduction—APOE—pancreatic cancer	0.0546	0.0546	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GDI2—pancreatic cancer	0.0288	0.0288	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GDI1—pancreatic cancer	0.0288	0.0288	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PRSS1—pancreatic cancer	0.0249	0.0249	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ZNRF3—pancreatic cancer	0.0249	0.0249	CbGpPWpGaD
Nitroxoline—METAP2—Disease—DTX1—pancreatic cancer	0.0225	0.0225	CbGpPWpGaD
Nitroxoline—METAP2—Disease—DTX4—pancreatic cancer	0.0189	0.0189	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRLHR—pancreatic cancer	0.0185	0.0185	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PPP2R5B—pancreatic cancer	0.0184	0.0184	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HEY2—pancreatic cancer	0.0177	0.0177	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ACVR1B—pancreatic cancer	0.0174	0.0174	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ZNRF3—pancreatic cancer	0.0174	0.0174	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HEY1—pancreatic cancer	0.0164	0.0164	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DTX1—pancreatic cancer	0.0158	0.0158	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SSTR3—pancreatic cancer	0.0158	0.0158	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SSTR1—pancreatic cancer	0.0151	0.0151	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PPY—pancreatic cancer	0.0148	0.0148	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SSTR2—pancreatic cancer	0.0146	0.0146	CbGpPWpGaD
Nitroxoline—METAP2—Disease—JAG2—pancreatic cancer	0.0145	0.0145	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MEN1—pancreatic cancer	0.0143	0.0143	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SLC2A2—pancreatic cancer	0.0142	0.0142	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCKBR—pancreatic cancer	0.0141	0.0141	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SHH—pancreatic cancer	0.0136	0.0136	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IAPP—pancreatic cancer	0.0135	0.0135	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DTX4—pancreatic cancer	0.0132	0.0132	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GLI1—pancreatic cancer	0.0132	0.0132	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HSPA1B—pancreatic cancer	0.0129	0.0129	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NRP1—pancreatic cancer	0.0129	0.0129	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.0129	0.0129	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HEY2—pancreatic cancer	0.0124	0.0124	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GAST—pancreatic cancer	0.0121	0.0121	CbGpPWpGaD
Nitroxoline—METAP2—Disease—JAG1—pancreatic cancer	0.0116	0.0116	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SCT—pancreatic cancer	0.0115	0.0115	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HEY1—pancreatic cancer	0.0115	0.0115	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CD44—pancreatic cancer	0.011	0.011	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCK—pancreatic cancer	0.0109	0.0109	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HSPA1A—pancreatic cancer	0.0109	0.0109	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CNR2—pancreatic cancer	0.0107	0.0107	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GLP1R—pancreatic cancer	0.0107	0.0107	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCKAR—pancreatic cancer	0.0105	0.0105	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JAG2—pancreatic cancer	0.0102	0.0102	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MEN1—pancreatic cancer	0.01	0.01	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SHH—pancreatic cancer	0.00955	0.00955	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOTCH4—pancreatic cancer	0.00949	0.00949	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IAPP—pancreatic cancer	0.00944	0.00944	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTHLH—pancreatic cancer	0.00906	0.00906	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTCH1—pancreatic cancer	0.00906	0.00906	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SMAD4—pancreatic cancer	0.00868	0.00868	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HES1—pancreatic cancer	0.00848	0.00848	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SST—pancreatic cancer	0.00828	0.00828	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JAG1—pancreatic cancer	0.00811	0.00811	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOTCH3—pancreatic cancer	0.00807	0.00807	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CNR1—pancreatic cancer	0.00765	0.00765	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TERT—pancreatic cancer	0.00743	0.00743	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GCG—pancreatic cancer	0.00738	0.00738	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HIF1A—pancreatic cancer	0.0071	0.0071	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TSC2—pancreatic cancer	0.00709	0.00709	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AGTR1—pancreatic cancer	0.00704	0.00704	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STK11—pancreatic cancer	0.00694	0.00694	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APOE—pancreatic cancer	0.00694	0.00694	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOTCH1—pancreatic cancer	0.0064	0.0064	CbGpPWpGaD
Nitroxoline—METAP2—Disease—EGF—pancreatic cancer	0.00619	0.00619	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SMAD4—pancreatic cancer	0.00608	0.00608	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HES1—pancreatic cancer	0.00594	0.00594	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CD—pancreatic cancer	0.0055	0.0055	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TERT—pancreatic cancer	0.0052	0.0052	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HIF1A—pancreatic cancer	0.00498	0.00498	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TSC2—pancreatic cancer	0.00496	0.00496	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APOE—pancreatic cancer	0.00486	0.00486	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CB—pancreatic cancer	0.0048	0.0048	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KDR—pancreatic cancer	0.00476	0.00476	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTGS2—pancreatic cancer	0.00475	0.00475	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NFKBIA—pancreatic cancer	0.00453	0.00453	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOTCH1—pancreatic cancer	0.00448	0.00448	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CG—pancreatic cancer	0.00438	0.00438	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EGF—pancreatic cancer	0.00433	0.00433	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CTNNB1—pancreatic cancer	0.00425	0.00425	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTEN—pancreatic cancer	0.00414	0.00414	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CD—pancreatic cancer	0.00385	0.00385	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SRC—pancreatic cancer	0.00384	0.00384	CbGpPWpGaD
Nitroxoline—METAP2—Disease—STAT3—pancreatic cancer	0.00371	0.00371	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NRAS—pancreatic cancer	0.0037	0.0037	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MYC—pancreatic cancer	0.00344	0.00344	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TGFB1—pancreatic cancer	0.00344	0.00344	CbGpPWpGaD
Nitroxoline—METAP2—Disease—EGFR—pancreatic cancer	0.00337	0.00337	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CB—pancreatic cancer	0.00336	0.00336	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCL8—pancreatic cancer	0.00323	0.00323	CbGpPWpGaD
Nitroxoline—METAP2—Disease—KRAS—pancreatic cancer	0.00318	0.00318	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CASP3—pancreatic cancer	0.00309	0.00309	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCND1—pancreatic cancer	0.00301	0.00301	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CTNNB1—pancreatic cancer	0.00298	0.00298	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CA—pancreatic cancer	0.00292	0.00292	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MMP9—pancreatic cancer	0.00292	0.00292	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTEN—pancreatic cancer	0.0029	0.0029	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HRAS—pancreatic cancer	0.00271	0.00271	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SRC—pancreatic cancer	0.00269	0.00269	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—VEGFA—pancreatic cancer	0.00262	0.00262	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STAT3—pancreatic cancer	0.0026	0.0026	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NRAS—pancreatic cancer	0.00259	0.00259	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MYC—pancreatic cancer	0.00241	0.00241	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TGFB1—pancreatic cancer	0.00241	0.00241	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT1—pancreatic cancer	0.00239	0.00239	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EGFR—pancreatic cancer	0.00236	0.00236	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KRAS—pancreatic cancer	0.00223	0.00223	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CA—pancreatic cancer	0.00205	0.00205	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TP53—pancreatic cancer	0.00198	0.00198	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HRAS—pancreatic cancer	0.00189	0.00189	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT1—pancreatic cancer	0.00167	0.00167	CbGpPWpGaD
